These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 22376190)

  • 1. Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the US.
    Ivanova JI; Bergman RE; Birnbaum HG; Phillips AL; Stewart M; Meletiche DM
    J Med Econ; 2012; 15(3):601-9. PubMed ID: 22376190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using observational analysis of multiple sclerosis relapse to design outcomes-based contracts for disease-modifying drugs: a feasibility assessment.
    Lage MJ; Carroll CA; Fairman KA
    J Med Econ; 2013 Sep; 16(9):1146-53. PubMed ID: 23844620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication adherence with disease modifying treatments for multiple sclerosis among US employees.
    Kleinman NL; Beren IA; Rajagopalan K; Brook RA
    J Med Econ; 2010; 13(4):633-40. PubMed ID: 20958113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct and indirect costs associated with Dupuytren's contracture.
    Macaulay D; Ivanova J; Birnbaum H; Sorg R; Skodny P
    J Med Econ; 2012; 15(4):664-71. PubMed ID: 22369346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
    Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
    Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs.
    Birnbaum HG; Ivanova JI; Samuels S; Davis M; Cremieux PY; Phillips AL; Meletiche D
    Curr Med Res Opin; 2009 Apr; 25(4):869-77. PubMed ID: 19232041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.
    Faught RE; Weiner JR; Guérin A; Cunnington MC; Duh MS
    Epilepsia; 2009 Mar; 50(3):501-9. PubMed ID: 19183224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US.
    Cohen R; Skup M; Ozbay AB; Rizzo J; Yang M; Diener M; Chao J
    J Med Econ; 2015 Jun; 18(6):447-56. PubMed ID: 25728698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between alternative medication possession ratio thresholds and outcomes: evidence from the use of glatiramer acetate.
    Oleen-Burkey MA; Dor A; Castelli-Haley J; Lage MJ
    J Med Econ; 2011; 14(6):739-47. PubMed ID: 21913796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort study.
    Steinberg SC; Faris RJ; Chang CF; Chan A; Tankersley MA
    Clin Drug Investig; 2010; 30(2):89-100. PubMed ID: 20067327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of cinacalcet adherence and costs in patients on dialysis.
    Lee A; Song X; Khan I; Belozeroff V; Goodman W; Fulcher N; Diakun D
    J Med Econ; 2011; 14(6):798-804. PubMed ID: 21988567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and costs of patients with persistent asthma treated with beclomethasone dipropionate hydrofluoroalkane or fluticasone propionate.
    Lage MJ; Gross GN; Brewster C; Spalitto A
    Adv Ther; 2009 Aug; 26(8):762-75. PubMed ID: 19669630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
    Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
    Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare resource utilization following switch or discontinuation in multiple sclerosis patients on disease modifying drugs.
    Reynolds MW; Stephen R; Seaman C; Rajagopalan K
    J Med Econ; 2010 Mar; 13(1):90-8. PubMed ID: 20078189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients.
    Karve S; Cleves MA; Helm M; Hudson TJ; West DS; Martin BC
    Med Care; 2008 Nov; 46(11):1125-33. PubMed ID: 18953222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs.
    Esposito D; Bagchi AD; Verdier JM; Bencio DS; Kim MS
    Am J Manag Care; 2009 Jul; 15(7):437-45. PubMed ID: 19589011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Descriptive analysis of the direct medical costs of multiple sclerosis in 2004 using administrative claims in a large nationwide database.
    Prescott JD; Factor S; Pill M; Levi GW
    J Manag Care Pharm; 2007; 13(1):44-52. PubMed ID: 17269836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The direct and indirect costs among U.S. privately insured employees with hypogonadism.
    Kaltenboeck A; Foster S; Ivanova J; Diener M; Bergman R; Birnbaum H; Kinchen K; Swindle R
    J Sex Med; 2012 Sep; 9(9):2438-47. PubMed ID: 22738380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of persistence with therapy on inpatient admissions and emergency room visits in the US among patients with multiple sclerosis.
    Thomas NP; Curkendall S; Farr AM; Yu E; Hurley D
    J Med Econ; 2016; 19(5):497-505. PubMed ID: 26706292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of infliximab adherence on Crohn's disease-related healthcare utilization and inpatient costs.
    Carter CT; Waters HC; Smith DB
    Adv Ther; 2011 Aug; 28(8):671-83. PubMed ID: 21818671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.